These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9587036)

  • 21. Homocysteine theory of atherosclerosis.
    Hladovec J
    Sb Lek; 1995; 96(3):225-30. PubMed ID: 8718812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperhomocysteinaemia in young adults is not associated with impaired endothelial function.
    Hanratty CG; McAuley DF; McGrath LT; Young IS; Johnston GD
    Clin Sci (Lond); 2001 Jan; 100(1):67-72. PubMed ID: 11115420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
    Hansrani M; Stansby G
    Cochrane Database Syst Rev; 2002; (3):CD003285. PubMed ID: 12137685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation.
    Chia S; Wilson R; Ludlam CA; Webb DJ; Flapan AD; Newby DE
    Clin Sci (Lond); 2005 Jan; 108(1):65-72. PubMed ID: 15367100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
    Sainani GS; Sainani R
    J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperhomocysteinaemia and atherothrombosis.
    Cattaneo M
    Ann Med; 2000 Dec; 32 Suppl 1():46-52. PubMed ID: 11209982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine and vascular dysfunction.
    Lentz SR
    Life Sci; 1997; 61(13):1205-15. PubMed ID: 9324062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
    Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The main determinants of endothelial dysfunction].
    Garaliene V
    Medicina (Kaunas); 2006; 42(5):362-9. PubMed ID: 16778463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperhomocysteinaemia and vascular disease.
    Townend J; O'Sullivan J; Wilde JT
    Blood Rev; 1998 Mar; 12(1):23-34. PubMed ID: 9597195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
    Riba R; Nicolaou A; Troxler M; Homer-Vaniasinkam S; Naseem KM
    Atherosclerosis; 2004 Jul; 175(1):69-75. PubMed ID: 15186948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
    den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Haak HL; Wijermans PW; Bos GM
    Lancet; 1995 Apr; 345(8954):882-5. PubMed ID: 7707810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperhomocysteinaemia in Behçet's disease.
    Aksu K; Turgan N; Oksel F; Keser G; Ozmen D; Kitapçioğlu G; Gümüşdiş G; Bayindir O; Doğanavşargil E
    Rheumatology (Oxford); 2001 Jun; 40(6):687-90. PubMed ID: 11426028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia.
    Dinckal MH; Aksoy N; Aksoy M; Davutoglu V; Soydinc S; Kirilmaz A; Dinckal N; Akdemir I
    Acta Cardiol; 2003 Oct; 58(5):389-96. PubMed ID: 14609303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients.
    Refai TM; Al-Salem IH; Nkansa-Dwamena D; Al-Salem MH
    Clin Rheumatol; 2002 Nov; 21(6):457-61. PubMed ID: 12447627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit.
    Shukla N; Koupparis A; Jones RA; Angelini GD; Persad R; Jeremy JY
    Eur J Pharmacol; 2006 Feb; 531(1-3):201-8. PubMed ID: 16451799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.